Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. (abbreviated as "Sinopharm Shuanglanxing") was established in 2007 with a registered capital of 89.9812 million yuan. The company has the production capacity of pharmaceutical granules, syrups, and mixtures, and has established Chinese medicine liquid preparations and Chinese medicine granules. The production line of medicine and Chinese medicine formula granules is producing more than 400 kinds of Chinese medicine formula granules with an annual output value of 200 tons. In March 2018, under the guidance of the national "One Belt One Road" policy and the strategic guidance of the "Implementation Plan for Heilongjiang Province and Guangdong Province Counterpart Cooperation", with the strong support of the leaders of the Provincial Party Committee and Hegang Municipal Party Committee, after several rounds of consultations and negotiations , Sinopharm Group successfully acquired Heilongjiang Shuanglanxing Pharmaceutical Co., Ltd. and changed its name to Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd., a subsidiary of China Traditional Chinese Medicine Holdings Co., Ltd., and a member company of China National Pharmaceutical Group. As one of the 200 key projects in Heilongjiang Province, it is the first enterprise in the province to produce traditional Chinese medicine formula granules. It fills the localization gap in the province's production of traditional Chinese medicine formula granules. It is also the first cooperation between Heilongjiang Province and Guangdong Province to successfully land and blossom. Results of the Chinese medicine industry project.